The Asia Pacific prenatal and newborn genetic testing market is expected to reach US$ 1,679.956 Mn in 2027 from US$ 630.914 in 2018. The market is estimated to grow with a CAGR of 11.6% from 2019-2027.
The key factors responsible for the growth of the Prenatal and Newborn Genetic testing market in Asia Pacific are rising burden of genetic diseases among infants, increasing fertility rates and developing healthcare scenario with rising awareness among populace regarding the benefits of prenatal testing. On the other hand, use of digital microfluidics in newborn testing is likely to be a prevalent trend in the future years.
Lucrative Regional Markets
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Burden of Genetic Diseases in India
Several types of genetic diseases affect the fetuses in the womb. The way in which these genetic diseases are inherited helps to determine the risk that they pose on pregnancy as well as the risk of its recurrence. The risk of having genetic diseases in babies is high in cases where the parents have another child with a genetic disease, family history of a genetic disorder, or if either of a parent has a chromosomal abnormality. There is a significant prevalence of genetic diseases among infants. Moreover, these diseases are also responsible for infant mortality across the globe. Five most common genetic diseases in India affecting the new born are Beta-Thalassemia, Cystic Fibrosis, Sickle Cell Anemia, Spinal Muscular Atrophy and Hemophilia A. Sickle cell anemia is inherited blood disorder and is most common among African, Arabian and Indian population. The Indian pediatrics estimated that every year approximately 9,000-10,000 new born suffer from β-thalassemia. Furthermore, in 2011, India reported 14,718 cases with bleeding diseases and 11,586 patients with hemophilia A.
Furthermore, according to the previous study, “The burden of genetic disorders in India and a framework for community control” in 2002, estimated that approximately, 495,000 new-borns with congenital malformations, 21,400 with Down syndrome, 9,000 with beta-thalassemia, 5,200 with sickle cell disease are born each year. Due to presence of large population, high birth rate, consanguineous marriage in various Indian communities, there is a high incidence of genetic diseases in India. Thus, the high prevalence of genetic diseases among infants account for the increasing demands for prenatal and newborn genetic tests, thereby contributing to the growth of the market.
Development of Policy for Treatment of Rare Diseases
Genetic diseases are, in most cases, chronic, devastating and life threatening, which often requires extensive and specialized treatments. Moreover, these diseases results in some form of disability, which may get extremely severe sometimes. These genetic diseases place a huge psychological, physical, and socioeconomic burden on patients as well as their families. The most common rare diseases are hemophilia, thalassemia, sickle-cell anemia, auto-immune diseases, lysosomal storage disorders and others. Approximately 80% of rare diseases have identified to be of genetic origin and hence have an impact on children.
The government of India (GOI) had constituted committees with the aim of framing a ‘national policy on treatment of 17 rare diseases’. Likewise, the government of National Capital Territory (NCT) of Delhi also appointed an interdisciplinary committee for rare diseases. Following are the committees appointed for rare diseases:
- Committee under Professor V.K. Paul, Head, Department of Paediatrics, AIIMS, New Delhi, for ‘Prioritisation of Therapy for Rare Genetic Disorders’
- Sub-committee on rare diseases in India, under Prof. I.C. Verma, Director, Institute of Medical Genetics Genomics, Sir Ganga Ram Hospital – ‘Guidelines for Therapy and Management’
Thus, growing efforts by the Government is likely to boost the market and is expected to provide significant growth opportunities for the prenatal and new born genetic testing market during the forecast period.
Product Insights
The Asia Pacific prenatal and newborn genetic testing market, based on the product was segmented into screening and diagnostics. In 2018, the screening segment held a largest market share of the prenatal and newborn genetic testing market, by product. Moreover, the same segment is also expected to witness the highest CAGR over the coming years owing to the factors such as increasing number of pregnant females adopting prenatal screening, increased mandatory regulations for newborn screening tests and others. Moreover, screens are the first line tests that pregnant women and newborn undergoes that also adds up to the major share of the market and its dominance in the Asia Pacific market.
Prenatal and newborn genetic testing Market, by Product
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Asia Pacific Prenatal & Newborn Genetic Testing Market: Strategic Insights
Market Size Value in US$ 630.914 Million in 2018 Market Size Value by US$ 1,679.956 Million by 2027 Growth rate CAGR of 11.6% from 2019-2027 Forecast Period 2019-2027 Base Year 2019
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Asia Pacific Prenatal & Newborn Genetic Testing Market: Strategic Insights
| Market Size Value in | US$ 630.914 Million in 2018 |
| Market Size Value by | US$ 1,679.956 Million by 2027 |
| Growth rate | CAGR of 11.6% from 2019-2027 |
| Forecast Period | 2019-2027 |
| Base Year | 2019 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Partnerships, Product up-gradation and product launches were observed as the most adopted strategy in Asia Pacific prenatal and newborn genetic testing industry. Few of the recent partnerships, product launch and up-gradations are listed below;
2019:
Illumina introduced VeriSeq NIPT Solution v2, a CE-IVD, next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT). The automated comprehensive solution allows laboratories to screen for a broader range of chromosomal and sub-chromosomal conditions associated with birth defects and adverse pregnancy outcomes than the standard NIPT menu.2017:
Natera, Inc. upgraded its Panorama non-invasive prenatal test (NIPT) to screen twin pregnancies for zygosity (identical or non-identical/fraternal) and chromosomal abnormalities.2015:
SRL Diagnostics has introduced a breakthrough medical test to diagnose hypertensive disorders in pregnancy recently at its state of the art lab in Gurgaon. PLGF (Placental Growth Factor) is used for accurate diagnosis and prognosis of “pre-eclampsia”, a major cause of maternal, foetal, neonatal morbidity and mortality.2017:
LifeCodexx AG, a non-invasive prenatal DNA testing company in Europe and LifeCell announced a partnership to bring PrenaTesT qNIPTTM testing for the first time to India. The qNIPT technology detects the presence of fetal trisomy 21 (Down syndrome) from maternal blood.PRENATAL AND NEWBORN GENETIC TESTING – MARKET SEGMENTATION
By Test Type
- Prenatal Genetic Testing
- Newborn Genetic Testing
By Product
- Screening
- Maternal Serum Screening
- Non-invasive Prenatal Testing
- Diagnostic
- Chronic Villus Sampling
- Amniocentesis
- Cytogenetic and Pharmacogenetic Testing
By Disease Indication
- Cystic Fibrosis
- Sickle Cell Anemia
- Down Syndrome
- Phenyketonuria
- Recurrent Pregnancy Loss
- Antiphospholipid Syndrome
- Other Diseases
By Technology
- Spectrophotometry
- Polymerase Chain Reaction
- Fluorescence in-situ Hybridization
- Array Competitive Genomic Hybridization
- Others
By End User
- Hospitals & Clinics
- Diagnostic Centres
- Other End Users
By Geography
Asia Pacific
- China
- Japan
- India
- Indonesia
- Singapore
- Malaysia
- Thailand
- Pakistan
- Bangladesh
- Sri Lanka
- Nepal
Company Profiles
- LifeCell
- Quest Diagnostics Incorporated
- Medgenome
- Eurofins Scientific
- Metropolis India
- SRL Diagnostics
- Sandor Lifesciences Pvt Ltd
- PerkinElmer, Inc.
- Natera, Inc.
- Laboratory Corporation of America Holdings (Sequenom)
- Genes2Me LLP
- Illumina, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Technology, End User and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Prenatal and Newborn Genetic Testing Market – By Product
1.3.2 Asia Pacific Prenatal and Newborn Genetic Testing Market – By Disease Indication
1.3.3 Asia Pacific Prenatal and Newborn Genetic Testing Market – By Technology
1.3.4 Asia Pacific Prenatal and Newborn Genetic Testing Market – By End User
1.3.5 Asia Pacific Prenatal and Newborn Genetic Testing Market – By Country
2. Asia Pacific Prenatal and Newborn Genetic Testing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Prenatal And Newborn Genetic Testing– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific – PEST Analysis
4.3 Expert Opinions
5. Asia Pacific Prenatal and Newborn Genetic Testing Market – Key Industry Dynamics
5.1 Key Drivers
5.1.1 Burden of Genetic Diseases in India
5.1.2 Increasing Fertility Rate
5.2 Key Restraints
5.2.1 Risks Associated with Prenatal Testing
5.3 Key Opportunities
5.3.1 Development of Policies for Treatment of Rare Diseases
5.4 Future Trends
5.4.1 Digital Microfluidics as New Opportunity Area for Newborn Screening
5.5 Impact Analysis
6. Prenatal And Newborn Genetic Testing Market – Asia Pacific Analysis
6.1 Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue Forecast And Analysis
6.2 Market Positioning
6.3 India Ultrasound Screening Market
6.3.1 Nuchal Translucency
6.3.1.1 Overview
6.3.1.2 Nuchal Translucency Market, revenue and forecast to 2027 (US$ Mn)
6.3.2 Fetal Nasal Bone Assessment
6.3.2.1 Overview
6.3.2.2 Fetal Nasal Bone Assessment Market, revenue and forecast to 2027 (US$ Mn)
6.3.3 Tricuspid Regurgitation
6.3.3.1 Overview
6.3.3.2 Tricuspid Regurgitation Market, revenue and forecast to 2027 (US$ Mn)
6.4 Pricing Analysis
6.5 Asia Pacific Prenatal And Newborn Genetic Testing Market, By Country, Volume And Forecast To 2027
6.5.1 China Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.2 China Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.3 Japan Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.4 Japan Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.5 India Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.6 India Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.7 Thailand Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.8 Thailand Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.9 Malaysia Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.10 Malaysia Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.11 Singapore Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.12 Singapore Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.13 Indonesia Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.14 Indonesia Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.15 Pakistan Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.16 Pakistan Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.17 Bangladesh Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.18 Bangladesh Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.19 Nepal Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.20 Nepal Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.21 Sri Lanka Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.22 Sri Lanka Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
7. Prenatal And Newborn Genetic Testing Market, By Product, Analysis And Forecast To 2027
7.1 Overview
7.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue Share, by Product, 2018 & 2027 (%)
7.3 Diagnostics
7.3.1 Overview
7.3.2 Diagnostics Market, revenue and forecast to 2027 (US$ Mn)
7.3.3 Amniocentesis
7.3.3.1 Overview
7.3.3.2 Amniocentesis Market, revenue and forecast to 2027 (US$ Mn)
7.3.4 Chorionic Villus Sampling
7.3.4.1 Overview
7.3.4.2 Chorionic Villus Sampling Market, revenue and forecast to 2027 (US$ Mn)
7.3.5 Cytogenetic and Pharmacogenetic Testing
7.3.5.1 Overview
7.3.5.2 Cytogenetic and Pharmacogenetic Testing Market, revenue and forecast to 2027 (US$ Mn)
7.4 Screening
7.4.1 Overview
7.4.2 Screening Market, revenue and forecast to 2027 (US$ Mn)
7.4.3 Maternal Serum Screening
7.4.3.1 Overview
7.4.3.2 Maternal Serum Screening Market, revenue and forecast to 2027 (US$ Mn)
7.4.4 Noninvasive Prenatal Testing
7.4.4.1 Overview
7.4.4.2 Noninvasive Prenatal Testing Market, revenue and forecast to 2027 (US$ Mn)
8. Prenatal And Newborn Genetic Testing Market Analysis And Forecast To 2027 – Disease Indication
8.1 Overview
8.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue Share, by Disease Indication, 2018 & 2027 (%)
8.3 Cystic Fibrosis
8.3.1 Overview
8.3.2 Cystic Fibrosis Market, Revenue And Forecast to 2027 (US$ Mn)
8.4 Sickle Cell Anemia
8.4.1 Overview
8.4.2 Sickle Cell Anemia Market, revenue and forecast to 2027 (US$ Mn)
8.5 Down Syndrome
8.5.1 Overview
8.5.2 Down syndrome Market, revenue and forecast to 2027 (US$ Mn)
8.6 Phenylketonuria
8.6.1 Overview
8.6.2 Phenylketonuria Market, revenue and forecast to 2027 (US$ Mn)
8.7 Recurrent Pregnancy Loss
8.7.1 Overview
8.7.2 Recurrent Pregnancy Loss Market, revenue and forecast to 2027 (US$ Mn)
8.8 Antiphospholipid Syndrome
8.8.1 Overview
8.8.2 Antiphospholipid Syndrome Market, revenue and forecast to 2027 (US$ Mn)
8.9 Other Diseases
8.9.1 Overview
8.9.2 Other Diseases Market, revenue and forecast to 2027 (US$ Mn)
9. Prenatal And Newborn Genetic Testing Market Analysis And Forecast To 2027 – Technology
9.1 Overview
9.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue Share, by Technology, 2018 & 2027 (%)
9.3 Spectrophotometer
9.3.1 Overview
9.3.2 Asia Pacific Spectrophotometer Market, Revenue And Forecast To 2027 (US$ Mn)
9.4 Polymerase Chain Reaction
9.4.1 Overview
9.4.2 Polymerase Chain Reaction Market, revenue and forecast to 2027 (US$ Mn)
9.5 Fluorescence In-situ Hybridization
9.5.1 Overview
9.5.2 Fluorescence in-situ Hybridization Market, revenue and forecast to 2027 (US$ Mn)
9.6 Array Comparative Genomic Hybridization Market
9.6.1 Overview
9.6.2 Array Comparative Genomic Hybridization Market, revenue and forecast to 2027 (US$ Mn)
9.7 Others
9.7.1 Overview
9.7.2 Others Market, revenue and forecast to 2027 (US$ Mn)
10. Prenatal And Newborn Genetic Testing Market Analysis And Forecast To 2027 – End User
10.1 Overview
10.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue Share, by End User, 2018 & 2027 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Asia Pacific Hospitals and Clinics Market, Revenue And Forecast To 2027 (US$ Mn)
10.4 Diagnostic Centers
10.4.1 Overview
10.4.2 Diagnostic Centers Market, revenue and forecast to 2027 (US$ Mn)
10.5 Other End Users
10.5.1 Overview
10.5.2 Other End Users Market, Revenue And Forecast To 2027 (US$ Mn)
11. Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 – Geographical Analysis
11.1 Asia Pacific Prenatal And Newborn Genetic Testing Market
11.1.1 Overview
11.1.2 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.1.3 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.1.4 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.1.4.1 Asia Pacific Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.1.4.2 Asia Pacific Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.1.5 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.1.6 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.1.7 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue and Forecast to 2027, By Country (%)
11.2.1 China Prenatal And Newborn Genetic Testing Market
11.2.1.1 China Prenatal And New born Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.1.2 China Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.1.3 China Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.1.3.1 China Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.1.3.2 China Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.1.4 China Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.1.5 China Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.1.6 China Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.2 Japan Prenatal And New born Genetic Testing Market
11.2.2.1 Japan Prenatal And New Born Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.2.2 Japan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.2.3 Japan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.2.3.1 Japan Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.2.3.2 Japan Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.2.4 Japan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.2.5 Japan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.2.6 Japan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.3 India Prenatal And New born Genetic Testing Market
11.2.3.1 India Prenatal and New born Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.3.2 India Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.3.3 India Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.3.3.1 India Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.3.3.2 India Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.3.4 India Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.3.5 India Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.3.6 India Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.4 Pakistan Prenatal And New born Genetic Testing Market
11.2.4.1 Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.4.2 Pakistan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.4.3 Pakistan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.4.3.1 Pakistan Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.4.3.2 Pakistan Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.4.4 Pakistan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.4.5 Pakistan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.4.6 Pakistan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.5 Sri Lanka Prenatal And New born Genetic Testing Market
11.2.5.1 Sri Lanka Prenatal And New born Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.5.2 Sri Lanka Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.5.3 Sri Lanka Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.5.3.1 Sri Lanka Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.5.3.2 Sri Lanka Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.5.4 Sri Lanka Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.5.5 Sri Lanka Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.5.6 Sri Lanka Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.6 Bangladesh Prenatal And New born Genetic Testing Market
11.2.6.1 Bangladesh Prenatal And New born Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.6.2 Bangladesh Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.6.3 Bangladesh Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.6.3.1 Bangladesh Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.6.3.2 Bangladesh Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.6.4 Bangladesh Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.6.5 Bangladesh Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.6.6 Bangladesh Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.7 Nepal Prenatal And New born Genetic Testing Market
11.2.7.1 Nepal Prenatal And New born Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.7.2 Nepal Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.7.3 Nepal Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.7.3.1 Nepal Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.7.3.2 Nepal Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.7.4 Nepal Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.7.5 Nepal Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.7.6 Nepal Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.8 Indonesia Prenatal And Newborn Genetic Testing Market
11.2.8.1 Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.8.2 Indonesia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.8.3 Indonesia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.8.3.1 Indonesia Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.8.3.2 Indonesia Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.8.4 Indonesia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.8.5 Indonesia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.8.6 Indonesia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.9 Singapore Prenatal And Newborn Genetic Testing Market
11.2.9.1 Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.9.2 Singapore Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.9.3 Singapore Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.9.3.1 Singapore Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.9.3.2 Singapore Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.9.4 Singapore Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.9.5 Singapore Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.9.6 Singapore Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.10 Malaysia Prenatal And Newborn Genetic Testing Market
11.2.10.1 Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.10.2 Malaysia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.10.3 Malaysia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.10.3.1 Malaysia Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.10.3.2 Malaysia Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.10.4 Malaysia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.10.5 Malaysia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.10.6 Malaysia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.11 Thailand Prenatal And Newborn Genetic Testing Market
11.2.11.1 Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.11.2 Thailand Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.11.3 Thailand Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.11.3.1 Thailand Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.11.3.2 Thailand Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.11.4 Thailand Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.11.5 Thailand Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.11.6 Thailand Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
12. Prenatal And Newborn Genetic Testing Market – Industry Landscape
12.1 Overview
12.2 Comparative Company Analysis
12.3 Growth Strategies Done by the Companies in the Market, (%)
12.4 Organic Developments
12.4.1 Overview
12.5 Inorganic Developments
12.5.1 Overview
13. Prenatal And Newborn Genetic Testing Market – Key Company Profiles
13.1 LifeCell
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Overview
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Quest Diagnostics Incorporated
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Overview
13.2.4 Product Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Medgenome
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Overview
13.3.4 Product Portfolio
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Eurofins Scientific
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Financial Overview
13.4.4 Product Portfolio
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Metropolis India
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Overview
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 SRL Diagnostics
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Financial Information
13.6.4 Product Portfolio
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Sandor Lifesciences Pvt. Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product Portfolio
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 PerkinElmer, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Overview
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Natera, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Financial Overview
13.9.4 Product Portfolio
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Laboratory Corporation Of America Holdings (Sequenom)
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 Product Portfolio
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Genes2Me LLP
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Financial Overview
13.11.4 Product Portfolio
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Illumina, Inc.
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Financial Overview
13.12.4 Product Portfolio
13.12.5 SWOT Analysis
13.12.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. China Screening Market, Volume And Forecast To 2027, By Type (Units)
Table 2. China Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
Table 3. Japan Screening Market, Volume And Forecast To 2027, By Type (Units)
Table 4. Japan Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
Table 5. India Screening Market, Volume And Forecast To 2027, By Type (Units)
Table 6. India Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
Table 7. Thailand Screening Market, Volume And Forecast To 2027, By Type (Units)
Table 8. Thailand Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
Table 9. Malaysia Screening Market, Volume And Forecast To 2027, By Type (Units)
Table 10. Malaysia Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
Table 11. Singapore Screening Market, Volume And Forecast To 2027, By Type (Units)
Table 12. Singapore Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
Table 13. Indonesia Screening Market, Volume And Forecast To 2027, By Type (Units)
Table 14. Indonesia Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
Table 15. Pakistan Screening Market, Volume And Forecast To 2027, By Type (Units)
Table 16. Pakistan Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
Table 17. Bangladesh Screening Market, Volume And Forecast To 2027, By Type (Units)
Table 18. Bangladesh Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
Table 19. Nepal Screening Market, Volume And Forecast To 2027, By Type (Units)
Table 20. Nepal Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
Table 21. Sri Lanka Screening Market, Volume And Forecast To 2027, By Type (Units)
Table 22. Sri Lanka Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
Table 23. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
Table 24. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
Table 25. Asia Pacific Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 26. Asia Pacific Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 27. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
Table 28. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
Table 29. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
Table 30. China Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
Table 31. China Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
Table 32. China Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 33. China Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 34. China Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
Table 35. China Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
Table 36. China Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
Table 37. Japan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
Table 38. Japan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
Table 39. Japan Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 40. Japan Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 41. Japan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
Table 42. Japan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
Table 43. Japan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
Table 44. India Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
Table 45. India Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
Table 46. India Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 47. India Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 48. India Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
Table 49. India Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
Table 50. India Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
Table 51. Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
Table 52. Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
Table 53. Pakistan Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 54. Pakistan Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 55. Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
Table 56. Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
Table 57. Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
Table 58. Sri Lanka Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
Table 59. Sri Lanka Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
Table 60. Sri Lanka Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 61. Sri Lanka Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 62. Sri Lanka Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
Table 63. Sri Lanka Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
Table 64. Sri Lanka Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
Table 65. Bangladesh Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
Table 66. Bangladesh Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
Table 67. Bangladesh Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 68. Bangladesh Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 69. Bangladesh Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
Table 70. Bangladesh Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
Table 71. Bangladesh Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
Table 72. Nepal Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
Table 73. Nepal Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
Table 74. Nepal Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 75. Nepal Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 76. Nepal Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
Table 77. Nepal Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
Table 78. Nepal Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
Table 79. Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
Table 80. Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
Table 81. Indonesia Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 82. Indonesia Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 83. Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
Table 84. Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
Table 85. Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
Table 86. Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
Table 87. Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
Table 88. Singapore Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 89. Singapore Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 90. Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
Table 91. Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
Table 92. Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
Table 93. Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
Table 94. Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
Table 95. Malaysia Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 96. Malaysia Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 97. Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
Table 98. Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
Table 99. Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
Table 100. Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
Table 101. Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
Table 102. Thailand Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 103. Thailand Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
Table 104. Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
Table 105. Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
Table 106. Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
Table 107. Organic Developments Done By Companies
Table 108. Inorganic Developments Done By Companies
Table 109. Glossary of Terms, Prenatal And Newborn Genetic Testing Market
LIST OF FIGURES
Figure 1. Prenatal And Newborn Genetic Testing Market Segmentation
Figure 2. India Prenatal And Newborn Genetic Testing Market, Revenue (US$ Mn),, 2018 & 2027
Figure 3. Asia Pacific Prenatal And Newborn Genetic Testing Market By Product, Market Share (%), 2018
Figure 4. Asia Pacific Prenatal And Newborn Genetic Testing Market By Disease Indication, Market Share (%), 2018
Figure 5. Asia Pacific Prenatal And Newborn Genetic Testing Market By Technology, Market Share (%), 2018
Figure 6. Asia Pacific Prenatal And Newborn Genetic Testing Market By End User, Market Share (%), 2018
Figure 7. Asia Pacific PEST Analysis
Figure 8. Prenatal And Newborn Genetic Testing Market: Impact Analysis of Driver And Restraints
Figure 9. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue Forecast And Analysis, 2018–2027
Figure 10. Nuchal Translucency Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 11. Fetal Nasal Bone Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 12. Tricuspid Regurgitation Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 13. Average Selling Price for Prenatal and Newborn Genetic Tests in China
Figure 14. Average Selling Price for Prenatal and Newborn Genetic Tests in Japan
Figure 15. Average Selling Price for Prenatal and Newborn Genetic Tests in India
Figure 16. Average Selling Price for Prenatal and Newborn Genetic Tests in Thailand
Figure 17. Average Selling Price for Prenatal and Newborn Genetic Tests in Malaysia
Figure 18. Average Selling Price for Prenatal and Newborn Genetic Tests in Singapore
Figure 19. Average Selling Price for Prenatal and Newborn Genetic Tests in Indonesia
Figure 20. Average Selling Price for Prenatal and Newborn Genetic Tests in Pakistan
Figure 21. Average Selling Price for Prenatal and Newborn Genetic Tests in Bangladesh
Figure 22. Average Selling Price for Prenatal and Newborn Genetic Tests in Nepal
Figure 23. Average Selling Price for Prenatal and Newborn Genetic Tests in Sri Lanka
Figure 24. Asia Pacific Prenatal and Newborn Genetic Testing Market Share, by Product, in Terms of Revenue, 2018 & 2027 (%)
Figure 25. Diagnostics Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 26. Amniocentesis Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 27. Chorionic Villus Sampling Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 28. Cytogenetic and Pharmacogenetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 29. Screening Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 30. Maternal Serum Screening Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 31. Noninvasive Prenatal Testing Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 32. Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue Share, by Disease Indication, 2018 & 2027 (%)
Figure 33. Cystic Fibrosis Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 34. Sickle Cell Anemia Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 35. Down syndrome Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 36. Phenylketonuria Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 37. Recurrent Pregnancy Loss Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 38. Antiphospholipid Syndrome Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 39. Other Diseases Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 40. Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue Share, by Technology, 2018 & 2027 (%)
Figure 41. Asia Pacific Spectrophotometer Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 42. Polymerase Chain Reaction Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 43. Fluorescence In-Situ Hybridization Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 44. Array Comparative Genomic Hybridization Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 45. Others Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 46. Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue Share, by End User, 2018 & 2027 (%)
Figure 47. Asia Pacific Hospitals and Clinics Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 48. Diagnostic Centers Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 49. Other End User Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 50. Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue Overview, By Country, 2018 (US$ MN)
Figure 51. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 52. Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue and Forecast to 2027, By Country (%)
Figure 53. China Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 54. Japan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 55. India Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 56. Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 57. Sri Lanka Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 58. Bangladesh Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 59. Nepal Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 60. Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 61. Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 62. Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 63. Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
Figure 64. Comparative Company Analysis
Figure 65. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Asia Pacific Prenatal and Newborn Genetic Testing Market
- LifeCell
- Quest Diagnostics Incorporated
- Medgenome
- Eurofins Scientific
- Metropolis India
- SRL Diagnostics
- Sandor Lifesciences Pvt Ltd
- PerkinElmer, Inc.
- Natera, Inc.
- Laboratory Corporation of America Holdings (Sequenom)
- Genes2Me LLP
- Illumina, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Prenatal & Newborn Genetic Testing Market
Nov 2019
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2019
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2019
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2019
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Nov 2019
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Nov 2019
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Nov 2019
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Nov 2019